We report on two adolescent sisters with Sanfilippo syndrome type D with some clinical features different from other cases previously described.
Sanfilippo syndrome (mucopolysaccharidosis III) is a hereditary disorder ofmucopolysaccharide metabolism characterised by heparan sulphate accumulation in tissues and excretion in urine. It is caused by deficiency of lysosomal enzymes required for heparan sulphate degradation. Four types of Sanfilippo syndrome are distinguished by the enzymatic defect: 2-deoxyglucoside-2-sulphamate sulphatase is deficient in type A, a-N-acetylglucosaminidase in type B, acetyl-CoA:a-glucosaminidase-N-acetyl-transferase in type C, and GlcNAc-6S sulphatase in type D. The clinical picture, consisting of mental retardation and mild somatic and visceral involvement, is similar in all four types so that the specific diagnosis is essentially biochemical. 1 So far, only six patients with Sanfilippo syndrome type D, aged 1 to 11 years, have been clinically described.24 Our report of two adolescent sisters affected with Sanfilippo syndrome type D expands the clinical spectrum and provides some clues about the quality and the expectancy of life in this disease.
Although GlcNAc-6S sulphatase has been well characterised5 and cDNA has been obtained, 6 individual cases of Sanfilippo type D disease have not been analysed at the molecular level.
In order to investigate the basis for the enzyme deficiency we have performed immunochemical and molecular studies on our patients' cells.
Case reports CASE 1 Patient 1 is a 19 year old girl of Italian origin, the first born of consanguineous (first cousins), healthy parents. The patient was born post-term by forceps delivery. The birth weight was 3200 g. The child's early milestones were mildly delayed: she was able to stand up at 1 year and to walk by herself at 2 years. Speech began at the age of 2/2 years and was limited to a few words. At the age of 4 the patient started to show progressive speech loss and aggressive behaviour. The regression of her psychomotor skills proceeded over a few years to a complete loss of contact with her environment and inability to walk unaided by the age of 10 years. The clinical examination showed: height 141 cm (<3rd centile), weight 4500 g (25th centile), and head circumference 54 cm (50th centile). The face was coarse and the hair was thick, curly, and dark with a low hairline. The eyebrows were thick with synophrys. She had a wide, flat nasal bridge, thick lips, and full cheeks ( fig IA) . Generalised hirsutism was present and the skin was cold to the touch. The hands were small and stubby and the feet had bilateral syndactyly of the third and fourth toes. Limitation of joint movements was present. The cardiac examination showed a grade 2/6 systolic ejection murmur located over the third to fourth intercostal space of the parasternal line. EKG showed sinus bradycardia. Hepatosplenomegaly was absent. Neurological examination showed clumsiness of fine movements and a waddling gait. The Zealand white rabbit to obtain antiserum.
Western blot analysis was carried out on fibroblast lysates obtained after three cycles of freeze-thawing, sonication, and centrifugation at 8000 g. The supernatant was subjected to electrophoresis on a 12% SDS-polyacrylamide gel (SDS-PAGE) and transferred to nitrocellulose by electroblotting. The nitrocellulose was immunostained with a 1:200 dilution of GIcNAc-6S sulphatase antiserum followed by alkaline phosphatase conjugated goat anti-rabbit antibodies.
Results
Northern blotting of mRNA hybridised with the GlcNAc-6S sulphatase probe showed two bands at 5 kb and 4-2 kb of equal intensity in both patients and one normal control. Rehybridisation of the filter with a cDNA probe for ,-hexosaminidase P chain resulted in a positive signal at 2-2 kb of equivalent intensity, indicating that approximately equal amounts of RNA had been applied in each lane (fig 2) . (fig 3) .
Endoglycosidase H treatment of fibroblast extracts followed by electrophoresis and immunoblotting resulted in a single band at 74 kd (data not shown), indicating that the 82 kd and 78 kd forms derive from different carbohydrate processing of the same polypeptide.
The 48 kd band present in the preparation of purified enzyme from liver was never detectable in fibroblasts from patients and normal controls, suggesting that different forms of GlcNAc-6S sulphatase are present in different tissues.
Discussion
Sanfilippo syndrome is the most common of the mucopolysaccharidoses' and is characterised by severe mental retardation and moderate somatic involvement. The first symptom is usually a mild delay of psychomotor development with onset between the ages of 2 to 6 years. Behavioural disturbances with irritability, aggressiveness, and progressive neurological deterioration follow, leading to dementia. Facial coarseness is less prominent than in other mucopolysaccharidoses. Growth retardation and corneal opacity are absent. Hepatosplenomegaly and bone dysplasia are mild. Sanfilippo syndrome type A is slightly more severe than type B, with earlier clinical onset and earlier age at death. Type C is considered intermediate in severity.9
So far, six cases of Sanfilippo syndrome type D have been described. The clinical symptoms follow the general pattern of Sanfilippo syndrome. Somatic signs are mild, always including coarse face, hirsutism, limitation of joint movements, and dysostosis multiplex. Mild to severe mental retardation has been reported in all patients.
Our patients exhibited the main clinical features described in the other cases of Sanfilippo syndrome type D, with the following differences. Both patients showed bilateral radial bowing, and no hirsutism or limitation of joint movements were present in patient 2. The course of the disease evolved rather differently in the two sisters. Psychomotor retardation in the infantile period was severe in patient 1 and only mild in patient 2. Neurological regression began at the age of 4 in patient 1 and at the age of II in her sister. In the previously reported cases of Sanfihippo syndrome type D, neurological regression occurred before the age of 4 in three cases, at the age of 8 in one, and was not evident in two patients (18 months old and 9 years old at the time of reporting). These findings may suggest the existence of two forms of Sanfilippo D syndrome according to the onset of mental and motor deterioration. Allelic mutations could be postulated for these clinical differences but, with respect to our patients, the occurrence of the two forms of the disease in the same sibship makes underlying genetic heterogeneity unlikely.
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